Tag: chronic conditions

In the specialized corridors of endocrine clinics, medical professionals and patients engage in a daily, high-stakes balancing act. This clinical tightrope walk, where synthetic hormones serve as the only safety net, determines the lifelong metabolic health of individuals living with congenital adrenal hyperplasia (CAH). Once considered a pediatric condition with high mortality rates, CAH has…

In a significant mobilization of scientific and medical expertise, the Endocrine Society recently concluded a high-impact virtual Hill Day, marking a pivotal moment in the organization’s ongoing efforts to shape federal policy regarding biomedical research and public health access. On March 13, more than 40 leading endocrinologists and researchers, representing diverse congressional districts across the…

Understanding the Pathophysiology of X-linked Hypophosphatemia At its core, XLH is a rare genetic disorder typically driven by mutations in the PHEX (Phosphate-regulating Endopeptidase Homolog, X-linked) gene located on the X chromosome. This genetic anomaly triggers a cascade of biochemical disruptions, primarily the overproduction of fibroblast growth factor 23 (FGF23). FGF23 is a hormone that…

The transition from a highly controlled hospital environment to the self-managed setting of a patient’s home represents one of the most volatile periods in the treatment of type 2 diabetes. A landmark prospective study recently published in the Journal of the Endocrine Society suggests that the integration of continuous glucose monitoring (CGM) technology at the…

This groundbreaking finding, published in the esteemed journal Hepatology, marks a significant shift in the medical community’s understanding of liver disease progression. Researchers from the Radcliffe Department of Medicine at the University of Oxford have identified fasting hyperinsulinemia not merely as a passive bystander or a symptom of metabolic syndrome, but as a primary driver…

The landscape of orphan drug development has reached a significant turning point this quarter as two major pharmaceutical entities, Amgen and Regeneron, reported pivotal clinical and regulatory milestones. These advancements target two debilitating and rare conditions: Thyroid Eye Disease (TED) and Fibrodysplasia Ossificans Progressiva (FOP). While the diseases differ significantly in their pathology—one being an…

The adrenal glands, though small in size, exert a profound influence over human physiology by regulating critical functions such as blood pressure, inflammation, the metabolic response to stress, and electrolyte balance. When these glands malfunction, the clinical consequences are often severe and life-altering. In observance of Adrenal Disease Awareness Month this April, the medical community…

The Endocrine Society has officially announced that Rebecca Reynolds, MD, PhD, a distinguished physician-scientist and academic leader, has been selected as the recipient of the 2026 International Excellence in Endocrinology Laureate Award. This prestigious honor recognizes Dr. Reynolds’ profound contributions to the understanding of metabolic medicine, specifically regarding the complex endocrine pathways that govern maternal…

The landscape of endocrine health and metabolic medicine underwent a significant shift this week as major pharmaceutical milestones and technological breakthroughs signaled a new era in patient care. Leading the developments was the U.S. Food and Drug Administration (FDA) approval of Novo Nordisk’s once-weekly basal insulin, a long-awaited advancement that promises to simplify the treatment…

The discovery of specific biological markers in the blood has provided a new window into the cardiovascular health of individuals living with HIV, offering the potential to predict the onset of dangerous arterial plaques years before they become visible on traditional medical scans. A landmark study published in The Journal of Clinical Endocrinology & Metabolism…